Paris Smith LLP advised Hampshire based Microsulis Medical Limited on the sale of substantially the whole of its global business and assets to AngioDynamics, Inc. NASDAQ listed AngioDynamics agreed to pay an initial $15m in cash. Substantial additional consideration is payable based on Microsulis’ performance over the next nine years.
Microsulis is a medical device company specialising in minimally invasive, microwave ablation products which are currently used in more than 80 hospitals world-wide.
The Paris Smith team was led by Corporate partner Michael Moore. Clare Lee (Property) and Stephanie Merritt (Employment) also advised. BDO’s Southanpton office advised Microsulis on tax aspects. Atlanta firm Ellis Funk advised on US law aspects.